These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 15192020)

  • 1. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury.
    Hilfiker-Kleiner D; Hilfiker A; Fuchs M; Kaminski K; Schaefer A; Schieffer B; Hillmer A; Schmiedl A; Ding Z; Podewski E; Podewski E; Poli V; Schneider MD; Schulz R; Park JK; Wollert KC; Drexler H
    Circ Res; 2004 Jul; 95(2):187-95. PubMed ID: 15192020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Many good reasons to have STAT3 in the heart.
    Hilfiker-Kleiner D; Hilfiker A; Drexler H
    Pharmacol Ther; 2005 Jul; 107(1):131-7. PubMed ID: 15963355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3-mediated activation of myocardial capillary growth.
    Hilfiker-Kleiner D; Limbourg A; Drexler H
    Trends Cardiovasc Med; 2005 May; 15(4):152-7. PubMed ID: 16099380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction.
    Obana M; Maeda M; Takeda K; Hayama A; Mohri T; Yamashita T; Nakaoka Y; Komuro I; Takeda K; Matsumiya G; Azuma J; Fujio Y
    Circulation; 2010 Feb; 121(5):684-91. PubMed ID: 20100971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning.
    Smith RM; Suleman N; Lacerda L; Opie LH; Akira S; Chien KR; Sack MN
    Cardiovasc Res; 2004 Sep; 63(4):611-6. PubMed ID: 15306216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart.
    Oshima Y; Fujio Y; Nakanishi T; Itoh N; Yamamoto Y; Negoro S; Tanaka K; Kishimoto T; Kawase I; Azuma J
    Cardiovasc Res; 2005 Feb; 65(2):428-35. PubMed ID: 15639482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Stat3 with HSF1 plays a critical role in G-CSF-induced cardio-protection against ischemia/reperfusion injury.
    Ma H; Gong H; Chen Z; Liang Y; Yuan J; Zhang G; Wu J; Ye Y; Yang C; Nakai A; Komuro I; Ge J; Zou Y
    J Mol Cell Cardiol; 2012 Jun; 52(6):1282-90. PubMed ID: 22426029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress.
    Donath S; Li P; Willenbockel C; Al-Saadi N; Gross V; Willnow T; Bader M; Martin U; Bauersachs J; Wollert KC; Dietz R; von Harsdorf R;
    Circulation; 2006 Mar; 113(9):1203-12. PubMed ID: 16505176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis.
    Urayama K; Guilini C; Messaddeq N; Hu K; Steenman M; Kurose H; Ert G; Nebigil CG
    FASEB J; 2007 Sep; 21(11):2980-93. PubMed ID: 17442730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction.
    Hilfiker-Kleiner D; Shukla P; Klein G; Schaefer A; Stapel B; Hoch M; Müller W; Scherr M; Theilmeier G; Ernst M; Hilfiker A; Drexler H
    Circulation; 2010 Jul; 122(2):145-55. PubMed ID: 20585009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury.
    Kempf T; Eden M; Strelau J; Naguib M; Willenbockel C; Tongers J; Heineke J; Kotlarz D; Xu J; Molkentin JD; Niessen HW; Drexler H; Wollert KC
    Circ Res; 2006 Feb; 98(3):351-60. PubMed ID: 16397141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis.
    Frias MA; Somers S; Gerber-Wicht C; Opie LH; Lecour S; Lang U
    Cardiovasc Res; 2008 Oct; 80(1):69-77. PubMed ID: 18567640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble receptor for advanced glycation end-products promotes angiogenesis through activation of STAT3 in myocardial ischemia/reperfusion injury.
    Cao X; Li B; Han X; Zhang X; Dang M; Wang H; Du F; Zeng X; Guo C
    Apoptosis; 2020 Jun; 25(5-6):341-353. PubMed ID: 32333220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age.
    Jacoby JJ; Kalinowski A; Liu MG; Zhang SS; Gao Q; Chai GX; Ji L; Iwamoto Y; Li E; Schneider M; Russell KS; Fu XY
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12929-34. PubMed ID: 14566054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-functional roles of Stat3 revealed by conditional gene targeting.
    Takeda K; Akira S
    Arch Immunol Ther Exp (Warsz); 2001; 49(4):279-83. PubMed ID: 11726030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressure overload induces cardiac dysfunction and dilation in signal transducer and activator of transcription 6-deficient mice.
    Hikoso S; Yamaguchi O; Higuchi Y; Hirotani S; Takeda T; Kashiwase K; Watanabe T; Taniike M; Tsujimoto I; Asahi M; Matsumura Y; Nishida K; Nakajima H; Akira S; Hori M; Otsu K
    Circulation; 2004 Oct; 110(17):2631-7. PubMed ID: 15492321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation.
    Sano S; Chan KS; Kira M; Kataoka K; Takagi S; Tarutani M; Itami S; Kiguchi K; Yokoi M; Sugasawa K; Mori T; Hanaoka F; Takeda J; DiGiovanni J
    Cancer Res; 2005 Jul; 65(13):5720-9. PubMed ID: 15994947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated STAT-1 pathway in the myocardium as a novel therapeutic target in ischaemia/reperfusion injury.
    Stephanou A
    Eur Cytokine Netw; 2002; 13(4):401-3. PubMed ID: 12517719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy.
    Frangogiannis NG; Dewald O; Xia Y; Ren G; Haudek S; Leucker T; Kraemer D; Taffet G; Rollins BJ; Entman ML
    Circulation; 2007 Feb; 115(5):584-92. PubMed ID: 17283277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.